查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790351

美国微阵列市场规模、份额和趋势分析报告：按产品/服务、类型、应用、最终用途和细分市场预测，2025 年至 2033 年

U.S. Microarray Market Size, Share & Trends Analysis Report By Product & Services (Instruments, Consumables, Software & Services), By Type (DNA Microarray, Protein Microarray), By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10个工作天内

价格

美国微阵列市场规模与趋势

预计 2024 年美国微阵列市场价值将达到 26.5 亿美元，预计 2025 年至 2033 年的复合年增长率为 5.7%。

个人化医疗（尤其是精准肿瘤学和药物基因组学）需求的蓬勃发展推动了市场的发展。随着美国国立卫生研究院 (NIH)、大学和生物技术公司不断增加的投资，微阵列在识别生物标记、分析基因表现、客製化治疗方法以及最终改善患者预后方面发挥着重要作用。此外，癌症和慢性病的日益普及也促使人们越来越依赖微阵列等先进的基因组工具进行早期检测和药物研发。

癌症研究的最新进展极大地促进了微阵列仪器和试剂的应用，以提高诊断准确性和分子分析能力。微阵列平台越来越多地用于基因表现分析，使研究人员能够识别癌症特异性生物标记、预测预后并指导标靶治疗。在美国，赛默飞世尔科技、安捷伦科技和 Illumina 等公司推出了针对高通量检测和低输入 RNA/DNA 样本而优化的尖端试剂组，这对于肿瘤切片检查分析至关重要。例如，赛默飞世尔的 GeneChip 研究试剂支持癌症研究中的全转录组分析，而安捷伦的 SureTag DNA 标记试剂套件可为癌细胞遗传学中的比较基因组杂合反应(CGH) 提供可靠的杂合反应。 Illumina 的 Infinium 检测试剂套件与 iScan 系统广泛相容，可同时分析甲基化和 SNP 图谱，支持表观遗传癌症研究。

美国微阵列技术的投资和创新不断扩大，预计将加速市场成长，尤其是在皮内贴剂等下一代应用领域。 2023年3月，总部位于麻萨诸塞州的生技公司Vaxes Technologies获得900万美元额外融资，推进其MIMIX缓释性皮内微阵列贴片平台。此创新平台旨在透过实现自我给药和经皮贴剂缓释性给药，彻底改变疫苗和治疗的给药方式。资金筹措由RA Capital Management和Enjin（麻省理工学院的创投基金）等知名美国投资者主导，将支持正在进行的流感疫苗和新冠疫苗临床试验，并拓展该平台在肿瘤学、自体免疫疾病和代谢性疾病领域的应用。

除了医疗保健领域，微阵列技术在美国农业和环境科学领域也蓬勃发展。在精密农业，微阵列技术被用于对植物基因组进行定序，并识别能够增强抗病虫害和气候压力的性状，从而应对美国的粮食安全挑战。此外，环境机构和学术机构越来越多地使用基于微阵列的毒理学基因组学检测来评估污染物对当地生态系统基因表现的影响。微阵列仪器和试剂的应用范围广泛，涵盖从临床研究到永续性的各个领域，它们在推动美国各个领域的创新方面发挥着越来越重要的作用。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国微阵列市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国微阵列市场分析工具
    • 产业分析波特五力分析
    • PESTEL分析

第四章美国微阵列市场：产品与服务、估价与趋势分析

  • 2024年和2033年的产品和服务市场占有率
  • 细分仪表板
  • 美国微阵列市场：产品与服务展望
  • 2021年至2033年市场规模、预测与趋势分析
    • 耗材
    • 装置
    • 软体和服务

第五章美国微阵列市场类型、估值与趋势分析

  • 2024年和2033年的类型市场占有率
  • 细分仪表板
  • 美国微阵列市场展望（按类型）
  • 2021年至2033年市场规模、预测与趋势分析
    • DNA微阵列
    • 蛋白质微阵列
    • 其他的

第六章：美国微阵列市场的应用、预测与趋势分析

  • 2024 年和 2033 年应用市场占有率
  • 细分仪表板
  • 美国微阵列市场：应用前景
  • 2021年至2033年市场规模、预测与趋势分析
    • 研究用途
    • 药物研发
    • 疾病诊断
    • 其他的

第七章美国微阵列市场：依最终用途的估计和趋势分析

  • 2024年和2033年的最终用途市场占有率
  • 细分仪表板
  • 美国微阵列市场：依最终用途分類的展望
  • 2021年至2033年市场规模、预测与趋势分析
    • 研究和学术机构
    • 製药和生物技术公司
    • 诊断实验室
    • 其他的

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Thermo Fisher Scientific Inc（Applied Biosystems）
    • Agilent Technologies, Inc
    • Illumina, Inc
    • PerkinElmer
    • Merck KGaA
    • Schott（Applied Microarrays）
    • Danaher Corporation
    • Arrayit Corporation
    • Bio-Rad Laboratories, Inc
    • Microarrays Inc
Product Code: GVR-4-68040-671-7

U.S. Microarray Market Size & Trends:

The U.S. microarray market size was estimated at USD 2.65 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2033. The market is driven by the surging demand for personalized medicine, especially in precision oncology and pharmacogenomics. With rising investments from the NIH, universities, and biotech firms, microarrays are invaluable for identifying biomarkers, profiling gene expression, and tailoring therapeutic regimens-ultimately improving patient outcomes. In addition, the escalating prevalence of cancer and chronic diseases further enhances reliance on high-throughput genomic tools like microarrays for early detection and drug discovery.

Recent advancements in cancer research have significantly leveraged microarray instruments and reagents to enhance diagnostic accuracy and molecular profiling. Microarray platforms are increasingly used for gene expression profiling, allowing researchers to identify cancer-specific biomarkers, predict prognosis, and guide targeted therapies. In the U.S., companies such as Thermo Fisher Scientific, Agilent Technologies, and Illumina have introduced updated reagent kits optimized for high-throughput assays and low input RNA/DNA samples-critical for analyzing tumor biopsies. For instance, Thermo Fisher's GeneChip reagents support whole-transcriptome analysis in oncology research, while Agilent's SureTag DNA labeling kits enable robust hybridization for comparative genomic hybridization (CGH) in cancer cytogenetics. Illumina's Infinium assay kits, widely compatible with the iScan system, allow for simultaneous interrogation of methylation and SNP profiles, aiding in epigenetic cancer studies.

Growing investment and innovation in U.S.-based microarray technologies are poised to accelerate market growth, particularly in next-generation applications such as intradermal patch delivery. In March 2023, Vaxess Technologies, a Massachusetts-based biotech firm, secured an additional USD 9 million in funding to advance its MIMIX sustained-release intradermal microarray patch platform. This novel platform aims to revolutionize vaccine and therapeutic delivery by enabling self-administered, extended-release dosing through a skin patch. The funding, led by prominent U.S. investors such as RA Capital Management and The Engine (MIT's venture fund), will support ongoing clinical trials for influenza and COVID-19 vaccines and broaden the platform's applications into oncology, autoimmune diseases, and metabolic disorders.

Beyond healthcare, microarray technologies are gaining momentum in U.S. agriculture and environmental science. In precision farming, microarrays are used to decode plant genomes and identify traits that enhance resistance to pests and climate stressors, which are addressing U.S. food security challenges. Additionally, environmental agencies and academic institutions are increasingly using microarray-based toxicogenomic assays to evaluate the impact of pollutants on gene expression in local ecosystems. This multifaceted applicability-from clinical research to sustainability continues to expand the role of microarray instruments and reagents in driving innovation across sectors in the United States.

U.S. Microarray Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. microarray market report based on products and services, type, application, and end use.

  • Product and Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
  • Software and Services
  • Instruments
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Microarrays
  • Protein Microarrays
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research Applications
  • Drug Discovery
  • Disease Diagnostics
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product and Services
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and Services Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Microarray Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for personalized medicine and genomic research
      • 3.2.1.2. Technological advancements in microarray platforms
      • 3.2.1.3. Expanding applications in diagnostics and infectious disease testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of microarray instruments and consumables
  • 3.3. U.S. Microarray Market Analysis Tools
    • 3.3.1. Industry Analysis Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Microarray Market: Product and Services Estimates & Trend Analysis

  • 4.1. Product and Services Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. U.S. Microarray Market by Product and Services Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Consumables
      • 4.4.1.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Software and Services
      • 4.4.3.1. Software and services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Microarray Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. U.S. Microarray Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. DNA Microarray
      • 5.4.1.1. DNA Microarray market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Protein Microarray
      • 5.4.2.1. Protein microarray market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Microarray Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. U.S. Microarray Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Research applications
      • 6.4.1.1. Research application market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Drug discovery
      • 6.4.2.1. Drug discovery market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Disease diagnostics
      • 6.4.3.1. Disease diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Others application market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. U.S. Microarray Market: End use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2024 & 2033
  • 7.2. Segment Dashboard
  • 7.3. U.S. Microarray Market by End use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 7.4.1. Research and Academic Institutes
      • 7.4.1.1. Research and Academic Institutes market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Pharmaceutical and Biotechnology Companies
      • 7.4.2.1. Pharmaceutical and Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Diagnostic Laboratories
      • 7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific Inc (Applied Biosystems)
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Services benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Agilent Technologies, Inc
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Services benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Illumina, Inc
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Services benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. PerkinElmer
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Services benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Services benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Schott (Applied Microarrays)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Services benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Danaher Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Services benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Arrayit Corporation
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Services benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Bio-Rad Laboratories, Inc
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Services benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Microarrays Inc
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Services benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 U.S. microarray market, by product and services, 2021 - 2033 (USD Million)
  • Table 4 U.S. microarray market, by type, 2021 - 2033 (USD Million)
  • Table 5 U.S. microarray market, by application, 2021 - 2033 (USD Million)
  • Table 6 U.S. microarray market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Market outlook
  • Fig. 9 Segment snapshot-1
  • Fig. 10 Segment snapshot-2
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Market trends & outlook
  • Fig. 13 Porter's five force analysis
  • Fig. 14 PESTEL analysis
  • Fig. 15 U.S. microarray market: Product and Services outlook key takeaways
  • Fig. 16 U.S. microarray market: Product and Services movement analysis
  • Fig. 17 U.S. Microarray: Product and Services movement analysis
  • Fig. 18 U.S. Microarray: Product and Services outlook and key takeaways
  • Fig. 19 Consumables market estimates and forecast, 2021 - 2033
  • Fig. 20 Instruments market estimates and forecast, 2021 - 2033
  • Fig. 21 Software and services market estimates and forecast, 2021 - 2033
  • Fig. 22 U.S. Microarray: Type movement analysis
  • Fig. 23 U.S. Microarray: Type outlook and key takeaways
  • Fig. 24 DNA microarray market estimates and forecasts, 2021 - 2033
  • Fig. 25 Protein microarray market estimates and forecasts, 2021 - 2033
  • Fig. 26 Others market estimates and forecasts, 2021 - 2033
  • Fig. 27 U.S. Microarray: Application movement analysis
  • Fig. 28 U.S. Microarray: application outlook and key takeaways
  • Fig. 29 Research applications market estimates and forecasts, 2021 - 2033
  • Fig. 30 Drug discovery market estimates and forecasts, 2021 - 2033
  • Fig. 31 Disease diagnostics market estimates and forecasts, 2021 - 2033
  • Fig. 32 Others applications market estimates and forecasts, 2021 - 2033
  • Fig. 33 U.S. Microarray: End Use movement analysis
  • Fig. 34 U.S. Microarray: End Use outlook and key takeaways
  • Fig. 35 Research and academic institutes market estimates and forecasts, 2021 - 2033
  • Fig. 36 Pharmaceutical and biotechnology companies market estimates and forecasts, 2021 - 2033
  • Fig. 37 Diagnostic laboratories market estimates and forecasts, 2021 - 2033
  • Fig. 38 Others market estimates and forecasts, 2021 - 2033